Elsevier

Dermatologic Clinics

Volume 23, Issue 4, October 2005, Pages 707-716
Dermatologic Clinics

A Critical Review of Quality-of-Life Scales for Psoriasis

https://doi.org/10.1016/j.det.2005.05.016Get rights and content

Section snippets

Short Form 36

The Short Form 36 (SF-36) consists of 36 items that measure 8 broad topics as listed in Box 1 [2], [3]. There is an additional question on change in respondents' health in the past year. For each variable, the items are converted into a scale from 0 (worst health state) to 100 (best health state).

Sickness Impact Profile assessment

The Sickness Impact Profile (SIP) is a broadly based assessment of performance of daily activities [4]. One hundred thirty-six individual statements relating to daily activities can be agreed or

A critical review of quality-of-life measures

Articles and abstracts in which all the quality-of-life measures are used are identified by searching MEDLINE and PubMed up to December 2004. All measures are summarized in Table 1.

Which measure to use?

In choosing which quality-of-life measure to use in psoriasis, first consider the reason for its use. This could be for clinical, research, audit, or financial purposes. If psoriasis is to be compared with other nondermatologic disease, a general health-related quality-of-life questionnaire is appropriate. If it is to be compared with other skin conditions, a dermatology-specific quality-of-life measure is likely to produce a more sensitive and meaningful comparison.

When deciding on a

First page preview

First page preview
Click to open first page preview

References (45)

  • C. Jenkinson et al.

    Short form 36 (SF-36) health survey questionnaire: normative data for adults of working age

    BMJ

    (1993)
  • A.M. Garratt et al.

    The SF36 health survey questionnaire: an outcome measure suitable for routine clinical use within the NHS?

    BMJ

    (1993)
  • M. Bergner et al.

    The Sickness Impact Profile: development and final revision of a health status measure

    Med Care

    (1981)
  • D.P. Goldberg et al.

    A scale version of the General Health Questionnaire

    Psychol Med

    (1979)
  • S.M. Hunt et al.

    The Nottingham Health Profile User's Manual

    (1989)
  • A.Y. Finlay et al.

    Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use

    Clin Exp Dermatol

    (1994)
  • M.S. Lewis-Jones et al.

    The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use

    Br J Dermatol

    (1995)
  • S.A. Holme et al.

    The Children's Dermatology Life Quality Index: validation of the cartoon version

    Br J Dermatol

    (2003)
  • M.M. Chren et al.

    Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin disease

    Arch Dermatol

    (1997)
  • M.M. Chren et al.

    Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases

    J Cutan Med Surg

    (2001)
  • M. Morgan et al.

    Dermatology quality of life scales – a measure of the impact of skin disease

    Br J Dermatol

    (1997)
  • T. Schafer et al.

    Development of the German scale for assessing quality of life in skin diseases

    Hautarzt

    (2001)
  • Cited by (23)

    • Quality-of-Life Instruments: Evaluation of the Impact of Psoriasis on Patients

      2012, Dermatologic Clinics
      Citation Excerpt :

      To be a useful QoL instrument, it should demonstrate the following criteria: (1) validity (ie, the instrument evaluates well what it intends to measure); (2) reliability (ie, the instrument is reproducible over time); (3) capable of measuring health-related QoL regardless of the disease severity (ie, the instrument can be used for patients with either mild-to-moderate or moderate-to-severe psoriasis); (4) applicable to a wide variety of patients in different clinical settings; and (5) quick and easy for patients to fill out. Several useful generic, dermatology-specific, and disease-specific QoL instruments exist to evaluate the impact of psoriasis on patient’s QoL.9–12 Specifically, generic QoL instruments given to patients with psoriasis include the Short Form 36 (SF-36),13,14 the Sickness Impact Profile (SIP),15 the General Health Questionnaire (GHQ),16 and the Psychological General Well-Being Index (PGWB).17

    View all citing articles on Scopus

    Prof. Finley is joint copyright owner of PDI, DLQI, and CDLQI. His department gains income from their use.

    View full text